Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells

Molecular Pharmacology

Volumn 49, Issue 1, 1996, Pages 63-72

  Schuetz, John D ^a   Schuetz, Erin G ^a   Thottassery, Jaideep V ^a   Guzelian, Philip S ^b   Strom, Stephen ^c   Sun, Daxi ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DEXAMETHASONE; GLUCOCORTICOID;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; DNA TRANSFECTION; DOSE RESPONSE; DRUG EFFECT; ENHANCER REGION; GENE ACTIVATION; GENE DELETION; GENE LOCATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BASE SEQUENCE; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; DNA; ENHANCER ELEMENTS (GENETICS); ENZYME ACTIVATION; HUMANS; LIVER; MAMMARY TUMOR VIRUS, MOUSE; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RATS; TUMOR CELLS, CULTURED;

EID: 0030059885     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Nelson, D. R., T Kamataki, D. J. Waxman, F. P. Guengerich, R. W. Estabrook, R. Feyereisen, F. J. Gonzalez, M J. Coon, I. C. Gunsalus, O. Gotoh, K. Okuda, and D. W. Nebert. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA Cell Biol. 12:1-51 (1993).
2. Nebert, D. W., D. R. Nelson, M. J. Coon, R. W. Estabrook, R. Feyereisen, Y. Fujii-Kuriyama, F. J. Gonzalez, F. P. Guengerich, I. C. Gunsalus, E. F. Johnson, J. C. Loper, R. Sato, M. R. Waterman, and D. J. Waxman. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 10:1-14 (1991).
3. Cresteil, T., C. Celier, P. Kremers, J. P. Flinois, P. Beaune, and J. P. Leroux. Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450. Br. J Clin. Pharmacol. 16:651-657 (1983).
4. Beaune, P., P. Kremers, F. Letawe-Goujon, and J. E. Gielen. Monoclonal antibodies against human liver cytochrome P-450. Biochem. Pharmacol. 34:3547-3552 (1985).
5. Molowa, D. T., E. G Schuetz, S. A. Wrighton, P. B. Watkins, P. Kremers, G. Mendez-Picon, G. A. Parker, and P. S. Guzelian. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc. Natl. Acad. Sci USA 83:5311-5315 (1986).
6. Beaune, P. H., D. R. Umbenhauer, R. W. Bork, R. S. Lloyd, and F. P. Guengerich. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc. Natl. Acad. Sci. USA 83:8064-8068 (1986).
7. Schuetz, J. D., D. T. Molowa, and P. S. Guzelian. Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch. Biochem. Biophys. 274:355-365 (1989)
8. Aoyama, T., S. Yamano, D. J. Waxman, D. P. Lapenson, U. A. Meyer, V. Fischer, R. Tyndale, T. Inaba, W. Kalow, H. V Gelboin, and F. J. Gonzalez. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J. Biol Chem. 264: 10388-10395 (1989).
9. Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa, and T. Kanakubo. P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16α-hydroxylase of dehydroepiandrosterone 3-sulfate. J. Biol. Chem. 262: 13534-13537 (1987)
10. Komori, M., K. Nishio, T. Fujitani, H. Ohi, M. Kitada, S. Mima, K. Itahashi, and T. Kamataki. Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch. Biochem. Biophys. 272:219-225 (1989).
11. Ged, C., J. M. Rouillon, L. Pichard, J. Combalbert, N. Bressot, P. Bories, H. Michel, P. Beaune, and P. Maurel. The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br. J. Clin Pharmacol. 28:373-387 (1989).
12. Kitada, M., and T. Kamataki. Partial purification and properties of cytochrome P450 from homogenates of human fetal livers. Biochem. Pharmacol. 28:793-797 (1979).
13. Hardwick, J. P., F. J. Gonzalez, and C. B. Kasper. Cloning of DNA complementary to cytochrome P-450 induced by pregnenolone-16 α-carbonitrile, characterization of its mRNA, gene, and induction response. J. Biol. Chem. 258:10182-10186 (1983).
14. Bork, R. W., T. Muto, P. H. Beaune, P. K. Srivastava, R. S. Lloyd, and F. P. Guengerich. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity J. Biol. Chem. 264:910-919 (1989).
15. Wrighton, S. A., W. R. Brian, M.-A. Sari, M. Iwasaki, F. P. Guengerich, J. L. Raucy, D. T. Molowa, and M. Vandenbranden. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38:207-213 (1990).
16. Wrighton, S. A., B. J. Ring, P. B. Watkins, and M. Vandenbranden. Identification of a polymorphically expressed member of the human cytochrome P-450III family. Mol. Pharmacol. 36:97-105 (1989).
17. Schuetz, J. D., D. L. Beach, and P. S. Guzelian. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20 (1994).
18. Jounaidi, Y , P. S. Guzelian, P. Maurel, and M.-J. Vilarem. Sequence of the 5′-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochem. Biophys. Res. Commun. 205:1741-1747 (1994).
19. Lukow, B., and G. Schutz. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490 (1987).
20. Shinomiya, T., G. Scherer, W. Schmid, H. Zentgraf, and G. Schutz. Isolation and characterization of the rat tyrosine aminotransferase gene. Proc. Natl. Acad Sci. USA 81:1346-1350 (1984).
21. Gorman, C. M., L. F. Moffat, and B. H. Howard. Recombinant genomes that express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell Biol. 2:1044-1051 (1982).
22. Giguere, V., S. M. Hollenberg, M. G. Rosenfeld, and R. M. Evans. Functional domains of the human glucocorticoid receptor. Cell 645:652 (1986).
23. Hollenberg, S. M., V. Giguere, and R. M. Evans. Identification of two regions of the human glucocorticoid receptor hormone binding domain that block activation. Cancer Res. 49(suppl.):2292s-2294s (1989).
24. Genetics Computer Group. Program Manual for the GCG Package, Ed. 7. Madison, WI, Genetics Computer Group, 1991.
25. Ausubel, F., R. Brent, R. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Strohl. Current Protocols in Molecular Biology. New York, John Wiley & Sons, 1987
26. Burger, H.-J., J. D. Schuetz, E. G. Schuetz, and P. S. Guzelian. Paradoxical transcriptional activation of rat liver cytochrome P450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 α-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. Proc. Natl. Acad. Sci. USA 89:2145-2149 (1992).
27. Schuetz, E. G., J. D. Schuetz, S. C. Strom, M. T. Thompson, R. A. Fisher, D. T. Molowa, D. Li, and P. S. Guzelian. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 18:1254-1262 (1993).
28. Isom, H. C., and I. Georgoff. Quantitative assay for albumin-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in chemically defined medium. Proc. Natl. Acad. Sci. USA 81:6478-6382 (1984).
29. Sleigh, M. J. A nonchromatographic assay for expression of the chloramphenicol acetyltransferases gene in eucaryotic cells. Anal. Biochem. 156: 251-256 (1986).
30. Martinez, E., and W. Wahli. Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J. 8:3781-3791 (1989).
31. Tully, D. B., and J. A. Cidlowski. Affinity of interactions between human glucocorticoid receptors and DNA: at physiologic ionic strength, stable binding occurs only with DNAs containing partially symmetric glucocorticoid response elements. Biochemistry 29:6662-6670 (1990).
32. Schuetz, E.G., and P. S. Guzelian. Induction of cytochrome P-450 by glucocorticoids in rat liver. II Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J. Biol. Chem. 259:2007-2012 (1984).
33. Schuetz, E. G., S. A. Wrighton, J. L. Barwick, and P. S. Guzelian. Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16 α-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver in vivo. J. Biol. Chem 259:1999-2006 (1984)
34. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science (Washington D. C.) 240:889-895 (1988).
35. Cato, A. C. B., P. Skroch, J. Weinmann, P. Butkeraitis, and H. Ponta. DNA sequences outside the receptor-binding sites differentially modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones. EMBO J. 7:1403-1410 (1099).
36. Muller, M., C. Baniahmad, C. Kaltschmidt, R. Schule, and R. Renkawitz. Co-operative transactivation of steroid receptors, in Nuclear Hormone Receptors: Molecular Mechanisms, Cellular Functions, Clinical Abnormalities (M. G. Parker, ed.). Harcourt Brace Jovanovich, Publishers, New York, 155-174 (1991).
37. Johnson, P. F. Transcriptional activators in hepatocytes. Cell Growth & Differ. 1:47-52 (199).
38. Danielsen, M. Structure and function of the glucocorticoid receptor, in Nuclear Hormone Receptors: Molecular Mechanisms, Cellular Functions, Clinical Abnormalities (M. G. Parker, ed.). Harcourt Brace Jovanovich, Publishers, New York, 39-78 (1991).
39. Guengerich, F. P. Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem. Res. Toxicol. 3:363-371 (1990).
40. Watkins, P B , S. A. Wrighton, P. Maurel, E G. Schuetz, G. Mendez-Picon, G. A. Parker, and P. S. Guzelian. Identification of an inducible form of cytochrome P-450 in human liver. Proc. Natl. Acad. Sci. USA 82:6310-6314 (1985).
41. Ham, J., M. Needham, P. Webb, and M. Parker. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumor virus. Nucleic Acids Res. 16:5263-5276 (1988).
42. Danesch, U., B. Gloss, W. Schmid, R. Schule, and R. Renkawitz. Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J. 6:625-630 (1987).
43. Schuetz, E. G., J. D. Schuetz, W. M. Grogan, A. N. Fejes-Toth, J. Raucy, P. S. Guzelian, and C. O. Watlington. Identification of the steroid inducible corticosterone 6β-hydroxylase in cultured epithelium of renal origin as a cytochrome P-450 related to the glucocorticoid inducible class III genes of mammalian liver and identification of some P450IIIA proteins in human kidney. Arch. Biochem. Biophys. 294:206-214 (1992).
44. Tully, D. B., and J. A. Cidlowski. Affinity of interactions between glucocorticoid receptors and DNA: at physiologic ionic strength, stable binding occurs only with DNAs containing partially symmetric glucocorticoid response elements. Biochemistry 29:6662-6670 (1990).